483
Bio-RadFDA 483 - Bio-Rad - May 16, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Bio-Rad in Steenvoorde, France, an IVD manufacturer, was inspected by the FDA from May 12-16, 2025. The inspection revealed one significant observation concerning the lack of documentation for process revalidation and incomplete risk analysis and design verification for a critical manufacturing process change. This issue impacts a peptide component used in their Geenius HIV 1/2 Supplemental Assay.
Open in Dashboard
ID · fd92ca34-74ec-459b-b233-709ce25c9d23